Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Profiling of microbiota in liquid baby formula consumed with an artificial nipple.

Sano H, Wakui A, Kawachi M, Kato R, Moriyama S, Nishikata M, Washio J, Abiko Y, Mayanagi G, Yamaki K, Sakashita R, Tomida J, Kawamura Y, Tanaka K, Takahashi N, Sato T.

Biomed Res. 2019;40(4):163-168. doi: 10.2220/biomedres.40.163.

2.

Spiny rat SRY lacks a long Q-rich domain and is not stable in transgenic mice.

Ogata Y, Nishikata M, Kitada K, Mizushima S, Jogahara T, Kuroiwa A.

Dev Dyn. 2019 Sep;248(9):784-794. doi: 10.1002/dvdy.73. Epub 2019 Jun 26.

PMID:
31219647
3.

[Development of a New Resilience Scale for Parents of Children with Profound Intellectual and Multiple Disabilities].

Tanaka M, Hisata M, Miyasaka M, Kurata K, Takizawa K, Nishikata M, Tohyama J, Seki N.

Nihon Eiseigaku Zasshi. 2019;74(0). doi: 10.1265/jjh.18025. Japanese.

4.

An Unusual Case of Acute Cholecystitis with Amyloidosis: A Case Report and Literature Review.

Matsuda S, Nishikata M, Takai K, Motoyoshi T, Yamashita Y, Kirishima T, Yoshinami N, Shintani H.

Intern Med. 2019 Mar 15;58(6):803-807. doi: 10.2169/internalmedicine.1805-18. Epub 2018 Nov 19.

5.

Development of hemiacetal esterified levofloxacin to prevent chelation with metal-containing drugs.

Otori T, Matzno S, Kawase A, Iwaki M, Kimachi T, Nishiwaki K, Figoni WC, Tominaga R, Asahide M, Nishikata M, Ishii Y, Matsuyama K.

J Pharm Pharmacol. 2016 Dec;68(12):1527-1534. doi: 10.1111/jphp.12642. Epub 2016 Oct 24.

PMID:
27774590
6.

Specific Shrinkage of Carotid Forks in Moyamoya Disease: A Novel Key Finding for Diagnosis.

Kuroda S, Kashiwazaki D, Akioka N, Koh M, Hori E, Nishikata M, Umemura K, Horie Y, Noguchi K, Kuwayama N.

Neurol Med Chir (Tokyo). 2015;55(10):796-804. doi: 10.2176/nmc.oa.2015-0044. Epub 2015 Sep 15.

7.

[Bacillus cereus septicemia and necrotizing fasciitis in a patient with liver cirrhosis: a case report].

Matsuda S, Kirishima T, Okamoto N, Hisano Y, Takai K, Motoyoshi T, Nishikata M, Yamashita Y, Yoshinami N, Shintani H.

Nihon Shokakibyo Gakkai Zasshi. 2014 Oct;111(10):2013-20. Review. Japanese.

PMID:
25283231
8.

Direct cholangioscopy combined with double-balloon enteroscope-assisted endoscopic retrograde cholangiopancreatography.

Koshitani T, Matsuda S, Takai K, Motoyoshi T, Nishikata M, Yamashita Y, Kirishima T, Yoshinami N, Shintani H, Yoshikawa T.

World J Gastroenterol. 2012 Jul 28;18(28):3765-9. doi: 10.3748/wjg.v18.i28.3765.

9.

Clear cell meningioma with histologically aggressive appearance and clinically aggressive behavior: a case report.

Hori S, Hayashi N, Ishizawa S, Hayashi S, Sato H, Nagao S, Akioka N, Nagai S, Nishikata M, Endo S.

Neuropathology. 2012 Aug;32(4):415-9. doi: 10.1111/j.1440-1789.2011.01272.x. Epub 2011 Nov 14.

PMID:
22082299
10.

Quantitative assessment of inter-observer variability in target volume delineation on stereotactic radiotherapy treatment for pituitary adenoma and meningioma near optic tract.

Yamazaki H, Shiomi H, Tsubokura T, Kodani N, Nishimura T, Aibe N, Udono H, Nishikata M, Baba Y, Ogita M, Yamashita K, Kotsuma T.

Radiat Oncol. 2011 Jan 27;6:10. doi: 10.1186/1748-717X-6-10.

11.

Cavernous sinus cavernous hemangioma largely extending into the sella turcica and mimicking pituitary adenoma: case report.

Hori S, Hayashi N, Nomoto K, Sato H, Hayashi T, Nagai S, Nishikata M, Endo S.

Neurol Med Chir (Tokyo). 2010;50(4):330-2.

12.

Methods of preventing vinorelbine-induced phlebitis: an experimental study in rabbits.

Kohno E, Murase S, Nishikata M, Okamura N, Matzno S, Kuwahara T, Matsuyama K.

Int J Med Sci. 2008 Jul 22;5(4):218-23.

14.

Carbonic anhydrase-related protein VIII promotes colon cancer cell growth.

Nishikata M, Nishimori I, Taniuchi K, Takeuchi T, Minakuchi T, Kohsaki T, Adachi Y, Ohtsuki Y, Onishi S.

Mol Carcinog. 2007 Mar;46(3):208-14.

PMID:
17219437
15.

Osteoprotegerin protects endothelial cells against apoptotic cell death induced by Porphyromonas gingivalis cysteine proteinases.

Kobayashi-Sakamoto M, Hirose K, Nishikata M, Isogai E, Chiba I.

FEMS Microbiol Lett. 2006 Nov;264(2):238-45. Epub 2006 Sep 19.

16.

Statistical analysis of the adverse effects of glycopeptide antibiotics, based on pharmacokinetics and toxicokinetics (PK/TK).

Yoshida M, Matzno S, Namba H, Nishikata M, Matsuyama K.

J Infect Chemother. 2006 Jun;12(3):114-8.

PMID:
16826342
17.

Continuous assay of protein tyrosine phosphatases based on fluorescence resonance energy transfer.

Nishikata M, Yoshimura Y, Deyama Y, Suzuki K.

Biochimie. 2006 Jul;88(7):879-86. Epub 2006 Feb 28.

18.

New recommendations for vancomycin dosage for patients with MRSA pneumonia with various degrees of renal function impairment.

Yoshida M, Yasuda N, Nishikata M, Okamoto K, Uchida T, Matsuyama K.

J Infect Chemother. 2005 Aug;11(4):182-8.

PMID:
16133709
19.

Evaluation of apoptosis and necrosis induced by statins using fluorescence-enhanced flow cytometry.

Yasuda N, Matzno S, Iwano C, Nishikata M, Matsuyama K.

J Pharm Biomed Anal. 2005 Sep 15;39(3-4):712-7.

PMID:
15927433
20.

Measurement of basilar artery bending and elongation by magnetic resonance cerebral angiography: relationship to age, sex and vertebral artery dominance.

Nishikata M, Hirashima Y, Tomita T, Futatsuya R, Horie Y, Endo S.

Arch Gerontol Geriatr. 2004 May-Jun;38(3):251-9.

PMID:
15066311
21.

Evaluation of myopathy risk for HMG-CoA reductase inhibitors by urethane infusion method.

Matsuyama K, Nakagawa K, Nakai A, Konishi Y, Nishikata M, Tanaka H, Uchida T.

Biol Pharm Bull. 2002 Mar;25(3):346-50.

22.

A new method for evaluating the bitterness of medicines by semi-continuous measurement of adsorption using a taste sensor.

Uchida T, Kobayashi Y, Miyanaga Y, Toukubo R, Ikezaki H, Taniguchi A, Nishikata M, Matsuyama K.

Chem Pharm Bull (Tokyo). 2001 Oct;49(10):1336-9.

23.

Preparation and characterization of insulin-loaded acrylic hydrogels containing absorption enhancers.

Uchida T, Toida Y, Sakakibara S, Miyanaga Y, Tanaka H, Nishikata M, Tazuya K, Yasuda N, Matsuyama K.

Chem Pharm Bull (Tokyo). 2001 Oct;49(10):1261-6.

24.

Inactivation of NF-kappaB involved in osteoblast development through interleukin-6.

Deyama Y, Takeyama S, Suzuki K, Yoshimura Y, Nishikata M, Matsumoto A.

Biochem Biophys Res Commun. 2001 Apr 20;282(5):1080-4.

PMID:
11302724
25.

Osteoblast maturation suppressed osteoclastogenesis in coculture with bone marrow cells.

Deyama Y, Takeyama S, Koshikawa M, Shirai Y, Yoshimura Y, Nishikata M, Suzuki K, Matsumoto A.

Biochem Biophys Res Commun. 2000 Jul 21;274(1):249-54.

PMID:
10903926
26.

T-kininogen and a 45 kda proteinase from Porphyromonas gingivalis.

Sakamoto W, Nishikata M, Fujie K, Handa H, Nishihira J.

Immunopharmacology. 1999 Dec;45(1-3):159-62.

PMID:
10615006
27.

A phosphotyrosine-containing quenched fluorogenic peptide as a novel substrate for protein tyrosine phosphatases.

Nishikata M, Suzuki K, Yoshimura Y, Deyama Y, Matsumoto A.

Biochem J. 1999 Oct 15;343 Pt 2:385-91.

28.

A low calcium environment enhances AP-1 transcription factor-mediated gene expression in the development of osteoblastic MC3T3-E1 cells.

Deyama A, Deyama Y, Matsumoto A, Yoshimura Y, Nishikata M, Suzuki K, Totsuka Y.

Miner Electrolyte Metab. 1999 May-Jun;25(3):147-60.

PMID:
10436400
29.

Early potentials of direct cortical responses: experimental study in dogs and pathophysiological and clinical implications.

Nishikata M, Endo S, Yamatani K, Hayashi N, Masuda R, Takaku A.

Neurosurgery. 1998 Aug;43(2):325-9.

PMID:
9696086
30.

Preparation and characterization of polylactic acid microspheres containing bovine insulin by a w/o/w emulsion solvent evaporation method.

Uchida T, Nagareya N, Sakakibara S, Konishi Y, Nakai A, Nishikata M, Matsuyama K, Yoshida K.

Chem Pharm Bull (Tokyo). 1997 Sep;45(9):1539-43.

PMID:
9332006
31.

Enhanced myopathy following administration of hypolipidemic agents under urethane anesthesia.

Nakai A, Nishikata M, Uchida T, Ichikawa M, Matsuyama K.

Biol Pharm Bull. 1997 Jan;20(1):104-6.

PMID:
9013820
32.

Drug interaction between simvastatin and cholestyramine in vitro and in vivo.

Nakai A, Nishikata M, Matsuyama K, Ichikawa M.

Biol Pharm Bull. 1996 Sep;19(9):1231-3.

PMID:
8889048
33.

Active site structure of a hemagglutinating protease from Porphyromonas gingivalis: similarity to clostripain.

Nishikata M, Yoshimura F.

Biochem Mol Biol Int. 1995 Oct;37(3):547-53.

PMID:
8595395
34.

Effect of first-pass metabolism on enantioselective pharmacokinetics after oral administration of (+)-, (-)- and racemic homochlorcyclizine to rats.

Nishikata M, Nakai A, Fushida H, Miyake K, Arita T, Iseki K, Miyazaki K.

Biol Pharm Bull. 1994 Sep;17(9):1267-71.

PMID:
7841951
35.
36.
38.

Enantioselective pharmacokinetics of homochlorcyclizine. III. Simultaneous determination of (+)- and (-)- homochlorcyclizine in human urine by high-performance liquid chromatography.

Nishikata M, Nakai A, Fushida H, Miyake K, Arita T, Iseki K, Miyazaki K, Nomura A.

J Chromatogr. 1993 Feb 26;612(2):239-44.

PMID:
8096848
39.

Method for optical resolution of racemic homochlorcyclizine and comparison of optical isomers in antihistamine activity and pharmacokinetics.

Nishikata M, Nakai A, Fushida H, Miyake K, Arita T, Kitagawa S, Kunitomo M, Iseki K, Miyazaki K.

Chem Pharm Bull (Tokyo). 1992 May;40(5):1341-2.

PMID:
1356640
40.

Effect of gastrointestinal maturation on absorption of beta-lactam antibiotics.

Morita E, Mizuno N, Nishikata M, Takahashi K.

J Pharm Sci. 1992 Apr;81(4):337-40.

PMID:
1501068
41.

Enantioselective pharmacokinetics of homochlorcyclizine. II: Disposition and metabolism of (+)-, (-)- and racemic homochlorcyclizine after oral administration to man.

Nishikata M, Nomura A, Iseki K, Miyazaki K, Nakai A, Fushida H, Miyake K, Arita T.

Eur J Clin Pharmacol. 1992;43(5):533-8.

PMID:
1362384
42.

Characterization of Porphyromonas (bacteroides) gingivalis hemagglutinin as a protease.

Nishikata M, Yoshimura F.

Biochem Biophys Res Commun. 1991 Jul 15;178(1):336-42.

PMID:
2069573
43.

Salivary histatin as an inhibitor of a protease produced by the oral bacterium Bacteroides gingivalis.

Nishikata M, Kanehira T, Oh H, Tani H, Tazaki M, Kuboki Y.

Biochem Biophys Res Commun. 1991 Jan 31;174(2):625-30.

PMID:
1993059
44.

Comparison of the pharmacokinetics of five beta-lactam antibiotics between neonatal and adult rats.

Morita E, Mizuno N, Nishikata M, Miyake K.

Dev Pharmacol Ther. 1990;14(4):223-30.

PMID:
2397676
45.

Involvement of prolyl endopeptidase in ascidian fertilization.

Yokosawa H, Nishikata M, Ishii S.

Experientia. 1989 Apr 15;45(4):381-3.

PMID:
2651143
46.
47.

Gastrointestinal absorption of sulfaguanidine in neonatal and adult rats.

Mizuno N, Nishikata M, Morita E, Miyake K.

J Pharmacobiodyn. 1986 Oct;9(10):787-92.

PMID:
3820055
48.

Gastrointestinal absorption of sulpiride in rat.

Mizuno N, Morita E, Nishikata M, Shinkuma D, Yamanaka Y.

Arch Int Pharmacodyn Ther. 1986 Sep;283(1):30-8.

PMID:
3800511
49.

Synthesis and structure of prolinal-containing peptides, and their use as specific inhibitors of prolyl endopeptidases.

Nishikata M, Yokosawa H, Ishii S.

Chem Pharm Bull (Tokyo). 1986 Jul;34(7):2931-6. No abstract available.

PMID:
3533287
50.

Frontal affinity chromatography: theory for its application to studies on specific interactions of biomolecules.

Kasai K, Oda Y, Nishikata M, Ishii S.

J Chromatogr. 1986 Apr 11;376:33-47.

PMID:
20213949

Supplemental Content

Loading ...
Support Center